“There’s no case where we get much below the current death rate, which is about 500 deaths a day, but there’s a significant risk we go back up to the even 2,000 a day.”
COVID-19 vaccine trials are well under way, but Bill Gates is not optimistic that phase III of these trials, which measures the efficacy and safety of a vaccine in a wide group of users, will be successful before the end of the year.
Read the full article here.
This content was originally published by Fast Company. Original publishers retain all rights. It appears here for a limited time before automated archiving. By Fast Company